127 related articles for article (PubMed ID: 16570007)
1. Successful organ transplantation from donors with Acinetobacter baumannii septic shock.
Cohen J; Michowiz R; Ashkenazi T; Pitlik S; Singer P
Transplantation; 2006 Mar; 81(6):853-5. PubMed ID: 16570007
[TBL] [Abstract][Full Text] [Related]
2. Successful solid organ transplantation from septicemic cadaveric donors: case report.
Sözen H; Fidan K; Mahli A; Singin E; Buyan N; Sindel S; Söylemezoğlu O; Arinsoy T; Dalgic A
Transplant Proc; 2008; 40(1):299-301. PubMed ID: 18261610
[TBL] [Abstract][Full Text] [Related]
3. [Bacteremia caused by Acinetobacter baumannii among patients in critical care].
Aguirre-Avalos G; Mijangos-Méndez JC; Zavala-Silva ML; Coronado-Magaña H; Amaya-Tapia G
Gac Med Mex; 2009; 145(1):21-5. PubMed ID: 19256407
[TBL] [Abstract][Full Text] [Related]
4. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes.
Robenshtok E; Paul M; Leibovici L; Fraser A; Pitlik S; Ostfeld I; Samra Z; Perez S; Lev B; Weinberger M
J Hosp Infect; 2006 Nov; 64(3):282-7. PubMed ID: 16930770
[TBL] [Abstract][Full Text] [Related]
5. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
[TBL] [Abstract][Full Text] [Related]
6. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients.
Falagas ME; Rafailidis PI; Matthaiou DK; Virtzili S; Nikita D; Michalopoulos A
Int J Antimicrob Agents; 2008 Nov; 32(5):450-4. PubMed ID: 18768302
[TBL] [Abstract][Full Text] [Related]
7. The high risk heart donor: potential pitfalls.
Bull DA; Stahl RD; McMahan DL; Jones KW; Hawkins JA; Renlund DG; Taylor DO; Karwande SV
J Heart Lung Transplant; 1995; 14(3):424-8. PubMed ID: 7654726
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients.
Bodro M; Sabé N; Tubau F; Lladó L; Baliellas C; Roca J; Cruzado JM; Carratalà J
Transplantation; 2013 Nov; 96(9):843-9. PubMed ID: 23883973
[TBL] [Abstract][Full Text] [Related]
9. Donors with positive blood culture: could they transmit infections to the recipients?
González-Segura C; Pascual M; García Huete L; Cañizares R; Torras J; Corral L; Santos P; Ramos R; Pujol M
Transplant Proc; 2005 Nov; 37(9):3664-6. PubMed ID: 16386498
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
[TBL] [Abstract][Full Text] [Related]
11. Use of hearts transplanted from donors with severe sepsis and infectious deaths.
Kubak BM; Gregson AL; Pegues DA; Leibowitz MR; Carlson M; Marelli D; Patel J; Laks H; Kobashigawa JA
J Heart Lung Transplant; 2009 Mar; 28(3):260-5. PubMed ID: 19285618
[TBL] [Abstract][Full Text] [Related]
12. Transplantation in the face of severe donor sepsis: pushing the boundaries?
Pauly RP; Rayner D; Murray AG; Gilmour SM; Kunimoto DY
Am J Kidney Dis; 2004 Oct; 44(4):e64-7. PubMed ID: 15384036
[TBL] [Abstract][Full Text] [Related]
13. Organ donation from a patient with bacterial meningoencephalitis -- the first case in Croatia.
Gopcević A; Gavranović Z; Pavlović M
Acta Clin Croat; 2011 Jun; 50(2):257-60. PubMed ID: 22263393
[TBL] [Abstract][Full Text] [Related]
14. Organ-cultured corneal grafts from septic donors: a retrospective study.
Spelsberg H; Reinhard T; Sengler U; Daeubener W; Sundmacher R
Eye (Lond); 2002 Sep; 16(5):622-7. PubMed ID: 12194079
[TBL] [Abstract][Full Text] [Related]
15. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens.
Poulakou G; Kontopidou FV; Paramythiotou E; Kompoti M; Katsiari M; Mainas E; Nicolaou C; Yphantis D; Antoniadou A; Trikka-Graphakos E; Roussou Z; Clouva P; Maguina N; Kanellakopoulou K; Armaganidis A; Giamarellou H
J Infect; 2009 Apr; 58(4):273-84. PubMed ID: 19344841
[TBL] [Abstract][Full Text] [Related]
16. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality.
Ye QF; Zhao J; Wan QQ; Qiao BB; Zhou JD
Transpl Infect Dis; 2014 Oct; 16(5):767-74. PubMed ID: 25124187
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.
Jang TN; Lee SH; Huang CH; Lee CL; Chen WY
J Hosp Infect; 2009 Oct; 73(2):143-50. PubMed ID: 19716203
[TBL] [Abstract][Full Text] [Related]
18. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
Mastoraki A; Douka E; Kriaras I; Stravopodis G; Saroglou G; Geroulanos S
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1086-90. PubMed ID: 18339553
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial infections in a medical-surgical intensive care unit.
Aly NY; Al-Mousa HH; Al Asar el SM
Med Princ Pract; 2008; 17(5):373-7. PubMed ID: 18685276
[TBL] [Abstract][Full Text] [Related]
20. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
